<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0520">
 <label>104</label>
 <mixed-citation publication-type="other" id="h0520">Praveen D, Puvvada RC, M VA. Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19. Int J Antimicrob Agents 2020;55:105967. https://doi.org/10.1016/j.ijantimicag.2020.105967.</mixed-citation>
</ref>
